Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
RVL Pharmaceuticals plc OSMT
$1.11
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
110176380.00000000
-
week52high
4.95
-
week52low
0.98
-
Revenue
177884000
-
P/E TTM
-1
-
Beta
1.95992400
-
EPS
-1.59900000
-
Last Dividend
0.00000000
-
Next Earnings Date
15 ноя 2021 г. в 05:00
Описание компании
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
HC Wainwright & Co. | Buy | 23 дек 2021 г. | |
Cantor Fitzgerald | Overweight | 24 сент 2021 г. | |
RBC Capital | Outperform | Outperform | 17 мар 2021 г. |
SVB Leerink | Outperform | Outperform | 10 июл 2020 г. |
SunTrust Robinson Humphrey | Buy | Buy | 10 июл 2020 г. |
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Schaub James | D | 396293 | 9607 | 24 янв 2022 г. |
deVries Tina Marie | D | 141588 | 9607 | 24 янв 2022 г. |
Klein Christopher | D | 201755 | 9607 | 24 янв 2022 г. |
Einhorn Andrew J. | D | 141473 | 9607 | 24 янв 2022 г. |
Schaub James | A | 405900 | 93800 | 16 дек 2021 г. |
deVries Tina Marie | A | 216944 | 216944 | 04 ноя 2021 г. |
MARKISON BRIAN A | A | 615000 | 615000 | 04 ноя 2021 г. |
Einhorn Andrew J. | A | 249814 | 249814 | 04 ноя 2021 г. |
Klein Christopher | A | 249814 | 249814 | 04 ноя 2021 г. |
Schaub James | A | 249814 | 249814 | 04 ноя 2021 г. |
Свежие комментарии
Свежие комментарии